NMRA:NASDAQ, Neumora Therapeutics, Inc.

Why NMRA stock fell on November 16

Neumora Therapeutics, Inc. fell 13.8% on Monday, November 16, 2026, on 1,493,700 shares. The headline around the move:

NMRA stock overview

Neumora Therapeutics, Inc. (NMRA:NASDAQ) closed at $0.334 on November 20, 2026, down 3.78% on the day. The stock trades 90.9% below its 52-week high of $3.65 and 10.9% above its 52-week low of $0.301. Over the past year, it lost 84.5%. Neumora Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.334
Day change
-3.78%
Volume
1,059,349
Average volume
1,678,029
Market cap
63M+
52-week range
$0.301 – $3.65
50-day average
$0.532
200-day average
$1.67

Price action over the past year

In 252 trading sessions since November 20, 2025, NMRA closed higher on 99 days (39%). Its best day was June 16, 2026 (+70.49%) and its worst was June 15, 2026 (-48.60%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

NMRA news

About Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021.

Similar stocks

Find more stocks like NMRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.